Xcellerant Ventures is a venture capital company that invests in technologies that power the future of healthtech and medtech.
Investment Type: Venture Capital
Investment Stage: Series A
Portfolio 9
Date | Name | Website | Total Raised | Location |
08.01.2024 | AdviNow Me... | advinow.co... | - | United Sta... |
05.01.2024 | CRISPR QC | crisprqc.c... | $11.6M | United Sta... |
- | Tesis Bios... | tesisbiosc... | - | United Sta... |
- | Anuncia Me... | anunciamed... | - | United Sta... |
- | Nanodroppe... | nanodroppe... | $1.4M | United Sta... |
- | TruLite He... | trulitehea... | $7M | United Sta... |
- | Rivia Heal... | riviahealt... | $3.25M | United Sta... |
- | Porter | helloporte... | $5.4M | United Sta... |
- | Treatment ... | tti.care | $1.5M | United Sta... |
Mentions in press and media 2
Date | Title | Description | Source |
05.01.2024 | CRISPR QC secures $10M Series A investment from Xcellerant V... | - | connect.or... |
22.05.2023 | Flinn Foundation Invests in Xcellerant Ventures’ Fund | The Flinn Foundation joined Xcellerant Ventures as a limited partner in its Xcellerant Venture Capit... | finsmes.co... |